Published in Cancer Weekly, August 5th, 1996
Vaccination sites such as the epidermis and oral mucosa have immune effector cells that are unique to their respective anatomic location. Cytokines have been demonstrated to have an immunostimulatory effect on these cells, and as such, may be exploited to enhance vaccine and antitumor responses.
Cancer immunotherapy has been shown successful against immunogenic and nonimmunogenic tumors. Many of these protocols rely on systemic cytokine administration to boost the immune response. Unfortunately, systemic cytokine administration at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.